drugset / Trial / NCT00211367

Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

NCT00211367 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Radiation retinopathy is a disease of the retina. It occurs in people who have received or been exposed to radiation near the eyes. The blood vessels are abnormal and may grow which lead to scarring and a loss of central vision. Currently, the treatment for radiation retinopathy is laser photocoagulation. This treatment has been found to have limited use in this type of condition. Compassionate use of anecortave acetate injection is being considered to prevent the growth of the blood vessels under the retina.

Timeline

Start
2004-04
Primary completion
—
Completion
2007-03

Outcome

Outcome not reported

Stopped (Enrollment): “poor enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Anecortave Acetate Unknown 15 mg Other

Indications

No indication recorded.